Clinical utility gene card for: von Hippel-Lindau (VHL).
作者信息
Decker Jochen, Neuhaus Christine, Macdonald Fiona, Brauch Hiltrud, Maher Eamonn R
机构信息
Clinic III-Hematology and Oncology, Medical School of Johannes Gutenberg University, Mainz, Germany.
Bioscientia, Center for Human Genetics, Ingelheim, Germany.
出版信息
Eur J Hum Genet. 2014 Apr;22(4). doi: 10.1038/ejhg.2013.180. Epub 2013 Aug 28.
Abstract
摘要
相似文献
1
Clinical utility gene card for: von Hippel-Lindau (VHL).
Eur J Hum Genet. 2014 Apr;22(4). doi: 10.1038/ejhg.2013.180. Epub 2013 Aug 28.
2
3
Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
Int J Neurosci. 2018 Feb;128(2):117-124. doi: 10.1080/00207454.2017.1372436. Epub 2017 Sep 13.
4
Clear cell chondrosarcoma in Von Hippel-Lindau disease.
Fam Cancer. 2020 Jan;19(1):41-45. doi: 10.1007/s10689-019-00149-1.
5
[Prenatal exclusion of von Hippel-Lindau syndrome in a Mexican family carrying a novel VHL gene mutation].
Ginecol Obstet Mex. 2013 Apr;81(4):206-10.
6
Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
BMC Med Genet. 2016 Jul 20;17(1):48. doi: 10.1186/s12881-016-0306-2.
7
Genotype-phenotype correlations in von Hippel-Lindau disease.
Hum Mutat. 2007 Feb;28(2):143-9. doi: 10.1002/humu.20385.
8
Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau disease.
Hum Mutat. 2022 Sep;43(9):1268-1285. doi: 10.1002/humu.24392. Epub 2022 May 10.
9
Mosaicism in von Hippel-Lindau disease with severe renal manifestations.
Clin Genet. 2013 Dec;84(6):581-4. doi: 10.1111/cge.12092. Epub 2013 Feb 5.
10
Von Hippel-Lindau syndrome: hereditary cancer arising from inherited mutations of the VHL tumor suppressor gene.
Cancer Treat Res. 1996;88:13-39. doi: 10.1007/978-1-4615-6343-3_2.
引用本文的文献
1
Anorexia as the first clinical manifestation of von Hippel-Lindau syndrome.
Mol Clin Oncol. 2020 Nov;13(5):65. doi: 10.3892/mco.2020.2135. Epub 2020 Sep 14.
2
DNA Methylation Dysfunction in Chronic Kidney Disease.
Genes (Basel). 2020 Jul 16;11(7):811. doi: 10.3390/genes11070811.
3
Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.
Clin Biochem Rev. 2017 Apr;38(2):69-100.
本文引用的文献
1
Genetic testing by cancer site: endocrine system.
Cancer J. 2012 Jul-Aug;18(4):364-71. doi: 10.1097/PPO.0b013e3182609458.
2
Systemic VHL gene functions and the VHL disease.
FEBS Lett. 2012 Jun 4;586(11):1562-9. doi: 10.1016/j.febslet.2012.04.032. Epub 2012 Apr 25.
3
Von Hippel-Lindau: how a rare disease illuminates cancer biology.
Semin Cancer Biol. 2013 Feb;23(1):26-37. doi: 10.1016/j.semcancer.2012.05.005. Epub 2012 May 30.
4
Clinical utility gene card for: familial erythrocytosis.
Eur J Hum Genet. 2012 May;20(5). doi: 10.1038/ejhg.2011.252. Epub 2012 Jan 25.
5
Complex cellular functions of the von Hippel-Lindau tumor suppressor gene: insights from model organisms.
Oncogene. 2012 May 3;31(18):2247-57. doi: 10.1038/onc.2011.442. Epub 2011 Sep 26.
6
von Hippel-Lindau disease: a clinical and scientific review.
Eur J Hum Genet. 2011 Jun;19(6):617-23. doi: 10.1038/ejhg.2010.175. Epub 2011 Mar 9.
7
Genotype-phenotype correlations in VHL exon deletions.
Am J Med Genet A. 2009 Oct;149A(10):2147-51. doi: 10.1002/ajmg.a.33023.
8
Alu-Alu recombination underlies the vast majority of large VHL germline deletions: Molecular characterization and genotype-phenotype correlations in VHL patients.
Hum Mutat. 2009 May;30(5):776-86. doi: 10.1002/humu.20948.
9
Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients.
Hum Mutat. 2007 Jun;28(6):613-21. doi: 10.1002/humu.20496.
10
Genotype-phenotype correlations in von Hippel-Lindau disease.
Hum Mutat. 2007 Feb;28(2):143-9. doi: 10.1002/humu.20385.
Zotero 插件